Histopathological evaluation of insulin-DMSO formula designed for direct nose-to-brain delivery

The combination of insulin and DMSO is a patented (Publication No US8987199B2), noninvasive, pharmaceutically strategized preparation for direct nose-to-brain delivery (DN2BD) suggested for the treatment of Alzheimer's disease (AD). Although its main ingredients have been individually researche...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Histology and histopathology 2022-05, Vol.37 (5), p.18421-439
Hauptverfasser:	Maher, Mustafa A, Kandeel, Wafaa, Hammam, Olfat A, Attia, Yasmeen M, Mahmoud, Soheir, Salah, Mohamed
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!